Bridgehead Technologies and Pharmalicensing Sign Merger Agreement.Business Editors/Health/Medical Writers MELTON mel·ton n. A heavy woolen cloth used chiefly for making overcoats and hunting jackets. [After Melton Mowbray, an urban district of central England.] MOWBRAY For the suburb of Cape Town, South Africa, see . Mowbray, the name of an Anglo-Norman baronial house, derived from Montbray (Manche) in Normandy south of St Lo. The heraldic badge of the house was a mulberry tree. , England--(BUSINESS WIRE)--May 9, 2003 A new and unique service providing strategic and licensing support to biopharmaceutical and medical companies Bridgehead bridge·head n. 1. a. A fortified position from which troops defend the end of a bridge nearest the enemy. b. A forward position seized by advancing troops in enemy territory as a foothold for further advance. Technologies Ltd and Pharmalicensing Ltd, two leading biopharmaceutical business development companies have announced a merger. Bridgehead Technologies Ltd is a leading specialist international consultancy providing due diligence Research; analysis; your homework. This term has caught on in all industries, because it sounds so "wired." Who would want to do analysis or research when they can do due diligence. See wired. , valuation and strategy advice to the life sciences and medical technologies sectors. Pharmalicensing Ltd is the leading global online partner for biopharmaceutical business development. The merger will form The Bridgehead Pharmalicensing Group Ltd. Bridgehead Technologies and Pharmalicensing will continue to trade under their own names, capitalising on the years of loyalty built by each brand. In addition, a powerful new product licensing and technology transfer service for medical and life sciences companies will be launched, backed by their joint expertise. In making the announcement, Dr Fiona Paton Pa·ton , Alan Stewart 1903-1988. South African writer noted for his novels Cry, the Beloved Country (1948) and Too Late the Phalarope (1953). He was a founder and leader (1953-1968) of the Liberal Party of South Africa. , Chairman of the new company said, "The merger represents a strategic move in a business-critical discipline. We have identified product sourcing in the pharmaceutical, medical and life sciences industries as a major growth area in the industry". "Late last year we strengthened our service offering by adding a global pricing and reimbursement Reimbursement Payment made to someone for out-of-pocket expenses has incurred. capability. Now clients will find the competitive edge we bring even further sharpened sharp·en tr. & intr.v. sharp·ened, sharp·en·ing, sharp·ens To make or become sharp or sharper. sharp by this merger", added David Alcraft, Director of Bridgehead Technologies. Bringing dealmakers together "We are delighted to have the opportunity to work together", said Steve v. t. 1. To pack or stow, as cargo in a ship's hold. See Steeve. Poile, founder and Managing Director of Pharmalicensing, "The depth and breadth of the combined group will be unrivalled. In addition to offering a more extensive range of online business development support tools, the new company will be uniquely positioned not only to bring dealmakers together but also to improve the efficiency of the whole licensing and acquisition process for client companies." International reach The Group will have offices and associates in all major countries; international headquarters will be in the UK. Full service The Group will offer both strategic and implementation services through all phases of product development and commercial lifecycles. By combining the resources and skills of the two companies, it will be in the position to offer high-level support in areas of portfolio decision-making decision-making, n the process of coming to a conclusion or making a judgment. decision-making, evidence-based, n a type of informal decision-making that combines clinical expertise, patient concerns, and evidence gathered from , product/corporate evaluation, intellectual property strategy, due diligence, setting and negotiating deal terms and pricing/reimbursement. Global strategy This merger is part of a strategy to build on the individual companies' strengths and to develop a full service business, supplying the needs of companies world wide, ranging from small biotechnology start-ups to leading pharmaceutical and medical companies. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion